Abstract Drug–target interaction (DTI) prediction is essential for drug discovery and repurposing. To overcome the limitations of current DTI prediction methods that rely on single-source encoding and inadequately fuse multimodal information, this study proposes a DTI prediction method based on multimodal information fusion (MIF–DTI) and further designs an ensemble version (MIF–DTI-B). MIF–DTI encodes the SMILES sequences of drugs and the amino acid sequences of targets via a sequence encoding module to extract their 1D sequence features. It conducts dual-view representation encoding on the hierarchical molecular graphs of drugs and the contact graphs of targets through a graph encoding module, aiming to capture their 2D topological structure information. A decoding module is utilized to fuse information from different modalities. MIF–DTI-B ensembles several MIF–DTI models through cross-validation strategy to improve predictive accuracy. This study evaluates the proposed models on three publicly accessible DTI datasets. Experimental results demonstrate that fully integrating multimodal information enables both MIF–DTI and MIF–DTI-B to consistently outperform state-of-the-art methods.
Shan et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: